Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase III trial of MP-thalidomide vs MP-lenalidomide in elderly, previously untreated symptomatic multiple myeloma
2007-004007-34Phase 3Active
- Sponsor
- HOVON
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in multiple myeloma (MM) comparing MP-thalidomide → thalidomide maintenance with MP-lenalidomide → lenalidomide maintenance (2 arms). Primary endpoint: Progression-free survival. Started Sep 2008; status: active.
02
Drugs
thalidomidelenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2007-004007-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004007-34.